Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Navidea Biopharmaceuticals Inc (NAVB)

AMEX: Health Care

Get a 5-page Ratings Report on (NAVB) now
$2.51 0.01 | 0.40%
Today's Range: 2.50 - 2.57
NAVB Avg. Daily Volume: 1,424,100
05/22/13 - 12:15 PM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: -8.75
  • Price Earnings Comparisons:
    NAVB Sector Avg. S&P 500
    -8.75 0.00 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    -17.51% -10.39% 0.00%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue -86.80 -0.99 -0.79
    Net Income -100.00 -0.23 0.00
    EPS -100.00 -0.46 0.00
  • Earnings for NAVB:
    EBITDA -27,989,303
    REVENUE 78,738
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $-0.06 $-0.05 $-0.25 $0.01
Number of Analysts 1 1 3 1
High Estimate $-0.06 $-0.05 $-0.21 $0.01
Low Estimate $-0.06 $-0.05 $-0.31 $0.01
Prior Year $-0.06 $-0.09 $-0.29 $-0.25
Growth Rate (Year over Year) 0.00% 44.44% 12.64% 103.95%
(NAVB) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,479.51 91.93 0.60%
NASDAQ 3,519.49 17.37 0.50%
S&P 500 1,679.86 10.70 0.64%
US 10 Yr 2.014% +0.070

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs